BusinessXOMA Reports Third Quarter 2016 Achievements and Financial ResultsBy Nasdaq OMXNov 9, 2016, 2:00 PM UTC
BusinessJeffrey Newman Law Announces $36 Million Settlement in Whistleblower Case Involving British Medical Device Company BTG and U.S. Department of JusticeBy Nasdaq OMXNov 7, 2016, 7:23 PM UTC
BusinessCempra Stock Trading Halted Today; FDA Advisory Committee to Discuss SolithromycinBy Nasdaq OMXNov 4, 2016, 11:05 AM UTC
BusinessPetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and NutraceuticalsBy Nasdaq OMXOct 19, 2016, 7:15 PM UTC
BusinessXOMA Announces Significant Step Toward Initiating Pediatric Phase 2 Clinical Study for XOMA 358 in Children with Congenital HyperinsulinismBy Nasdaq OMXOct 19, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration SubmissionBy Nasdaq OMXOct 13, 2016, 12:02 PM UTC
BusinessSummit Receives Rare Pediatric Disease Designation From US FDA for Ezutromid in Treatment of Duchenne Muscular DystrophyBy Nasdaq OMXSep 27, 2016, 11:00 AM UTC
